News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Industry News Corvent Medical, A Coridea Portfolio Company, Closes $4.5m Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator May 11, 2020
News Industry News Robocath secures €40 million series C financing round to deploy its operations development plan April 29, 2020
News Industry News Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott October 09, 2019
News Industry News SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz July 11, 2019
News Industry News Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years July 08, 2019
News Industry News Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases May 16, 2019
News Industry News Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering May 14, 2019
News Industry News Intelligent Data Analytics Software Solution Comes To Electrophysiology With Launch Of Biosense Webster’s Cartonet May 07, 2019
News Industry News Corindus Equips the World’s First Fully Robotic Catheterization Laboratory May 07, 2019
News Industry News Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System May 06, 2019
News Industry News Medtronic Receives FDA Approval for CareLink SmartSync Device Manager May 02, 2019
News Industry News Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial April 19, 2019
News Industry News TriNetX's Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension April 18, 2019
News Industry News Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training January 24, 2018
News Industry News Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death October 02, 2017